Grady Burnett - 30 Jun 2021 Form 4 Insider Report for Kaleido Biosciences, Inc.

Role
Director
Signature
/s/ Jerald Korn, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jul 2021, 16:42:47 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 30 Jun 2021 Common Stock 15,000 $7.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.